These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 8988029

  • 1. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS, Franklin WA, Otstot JT, Forbey K, Varella-Garcia M, Rao K, Drabkin H, Gemmill R, Ahrent S, Sidransky D, Saccomanno G, Fountain JW, Anderson MW.
    Cancer Res; 1997 Jan 01; 57(1):1-6. PubMed ID: 8988029
    [Abstract] [Full Text] [Related]

  • 2. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Wiest JS, Franklin WA, Drabkin H, Gemmill R, Sidransky D, Anderson MW.
    J Cell Biochem Suppl; 1997 Jan 01; 28-29():64-73. PubMed ID: 9589350
    [Abstract] [Full Text] [Related]

  • 3. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP, Taylor JA, White CM, Anna CH, Barrett JC, Devereux TR.
    Clin Cancer Res; 1995 Jul 01; 1(7):687-90. PubMed ID: 9816033
    [Abstract] [Full Text] [Related]

  • 4. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P, Tokino K, Eby Y, Sidransky D.
    Cancer Res; 1995 Jan 15; 55(2):224-7. PubMed ID: 7812948
    [Abstract] [Full Text] [Related]

  • 5. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.
    An HX, Niederacher D, Picard F, van Roeyen C, Bender HG, Beckmann MW.
    Genes Chromosomes Cancer; 1996 Sep 15; 17(1):14-20. PubMed ID: 8889502
    [Abstract] [Full Text] [Related]

  • 6. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI, Minna JD.
    Cancer Res; 2000 Nov 01; 60(21):6116-33. PubMed ID: 11085536
    [Abstract] [Full Text] [Related]

  • 7. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR, Spruck CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA.
    Cancer Res; 1996 Nov 01; 56(21):5039-43. PubMed ID: 8895761
    [Abstract] [Full Text] [Related]

  • 8. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC, Godwin AK.
    Cancer Res; 1995 May 15; 55(10):2150-7. PubMed ID: 7743516
    [Abstract] [Full Text] [Related]

  • 9. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
    Schmid M, Malicki D, Nobori T, Rosenbach MD, Campbell K, Carson DA, Carrera CJ.
    Oncogene; 1998 Nov 19; 17(20):2669-75. PubMed ID: 9840931
    [Abstract] [Full Text] [Related]

  • 10. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
    Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L, Mao L, Jen J, Sidransky D.
    Cancer Res; 1997 Dec 01; 57(23):5356-9. PubMed ID: 9393760
    [Abstract] [Full Text] [Related]

  • 11. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE, Gorgoulis V, Mariatos G, Zacharatos P, Kotsinas A, Garinis G, Trigidou R, Karameris A, Tsimara-Papastamatiou H, Kouloukousa M, Manolis EN, Kittas C.
    Anticancer Res; 1999 Dec 01; 19(3A):1893-9. PubMed ID: 10470133
    [Abstract] [Full Text] [Related]

  • 12. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM, Welch J, Hayward NK.
    Cancer Res; 2001 Feb 01; 61(3):1154-61. PubMed ID: 11221846
    [Abstract] [Full Text] [Related]

  • 13. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B, Goharderakhshan R, Chang J, Ribeiro-Filho LA, Perinchery G, Franks J, Presti J, Carroll P, Dahiya R.
    J Urol; 2001 Sep 01; 166(3):1088-92. PubMed ID: 11490304
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 01; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 15. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 01; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 16. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
    Cairns P, Tokino K, Eby Y, Sidransky D.
    Cancer Res; 1994 Mar 15; 54(6):1422-4. PubMed ID: 8137242
    [Abstract] [Full Text] [Related]

  • 17. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ, Aldaz CM.
    Cancer Res; 1995 Jul 01; 55(13):2892-5. PubMed ID: 7796417
    [Abstract] [Full Text] [Related]

  • 18. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer.
    Merlo A, Gabrielson E, Mabry M, Vollmer R, Baylin SB, Sidransky D.
    Cancer Res; 1994 May 01; 54(9):2322-6. PubMed ID: 8162574
    [Abstract] [Full Text] [Related]

  • 19. Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer.
    Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Fong KM, Sekido Y, Minna JD, Hong WK, Mao L.
    Cancer Res; 1997 Feb 01; 57(3):400-3. PubMed ID: 9012464
    [Abstract] [Full Text] [Related]

  • 20. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
    Balázs M, Carroll P, Kerschmann R, Sauter G, Waldman FM.
    Genes Chromosomes Cancer; 1997 Jun 01; 19(2):84-9. PubMed ID: 9171998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.